Nu Skin formulates peptides
This article was originally published in The Rose Sheet
Executive SummaryPersonal care products formulated with a new proprietary technology will debut in the third and fourth quarters of 2004 under partnership with German pharmaceutical firm Cosmix, direct-seller says March 13. Cosmix, which specializes in peptide and protein ingredient technologies, will help Nu Skin create a pipeline of "scientifically-advanced" products, Provo, Utah marketer states. Deal is expected to increase demand for Nu Skin's products and to "drive greater distributor activity over the next several years," company adds. Technology, which is in the first phase of a four-stage development process, also could be incorporated into existing products. Pentapeptide technology currently is used in Nu Skin's Tru Face Line Corrector anti-aging product...
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.